1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Gennex Laboratories Limited

Gennex Laboratories Limited

GENNEX.BO
Gennex Laboratories LimitedIN flagBombay Stock Exchange
10.09
INR
-0.15
- -
2.45BMarket Cap

Total Valuation

Gennex Laboratories Limited carries a market capitalization of 2.45B, placing it among publicly traded companies globally. Its enterprise value stands at 1.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.45B
Enterprise Value1.07B

Share Statistics

Gennex Laboratories Limited currently has 242.95M shares outstanding.

Shares Outstanding242.95M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Gennex Laboratories Limited trades at a trailing price-to-earnings ratio of 9.05. The price-to-sales ratio is 1.03, and the price-to-book ratio stands at 7.36.

PE Ratio9.05
PS Ratio1.03
PB Ratio7.36
P/TBV Ratio0.78
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Gennex Laboratories Limited trades at an EV/EBITDA multiple of 4.37 and an EV/FCF ratio of 28.12. The EV/Sales ratio of 0.62 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.37 provides insight into valuation relative to core operating earnings.

EV / Sales0.62
EV / EBITDA4.37
EV / EBIT4.37
EV / FCF28.12

Financial Position

Gennex Laboratories Limited maintains a current ratio of 3.66, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.08, indicating elevated leverage, while an interest coverage ratio of 5.82 demonstrates adequate ability to service its debt obligations.

Current Ratio3.66
Quick Ratio2.23
Debt / Equity34.08
Debt / EBITDA3.25
Interest Coverage5.82

Financial Efficiency

Gennex Laboratories Limited posts a return on equity of 38.23 and a return on invested capital of 8.03.

Return on Equity (ROE)38.23
Return on Assets (ROA)6.53
Return on Invested Capital (ROIC)8.03
Return on Capital Employed (ROCE)19.57
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.86

Taxes

Over the trailing twelve months, Gennex Laboratories Limited has paid 22.59M in income taxes, reflecting an effective tax rate of 9.60.

Income Tax22.59M
Effective Tax Rate9.60

Stock Price Statistics

Gennex Laboratories Limited's stock has declined approximately -18.82542% over the past 52 weeks. The 50-day moving average sits at 10.62, while the 200-day moving average is 11.96.

Beta (5Y)N/A
52-Week Price Change-18.82542%
50-Day Moving Average10.62
200-Day Moving Average11.96
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Gennex Laboratories Limited generated 1.73B in revenue and converted that into 197.44M in net income, yielding earnings per share of 0.83. EBITDA reached 244.40M, while operating income came in at 244.40M.

Revenue1.73B
Gross Profit442.16M
Operating Income244.40M
Pretax Income235.38M
Net Income197.44M
EBITDA244.40M
EBIT244.40M
Earnings Per Share (EPS)0.83

Balance Sheet

Gennex Laboratories Limited holds 1.62B in cash and equivalents against 793.61M in total debt, resulting in a net debt position of 793.03M. Total book value stands at 242.95M, with working capital of 1.92B providing operational flexibility.

Cash & Cash Equivalents1.62B
Total Debt793.61M
Net Debt793.03M
Equity (Book Value)242.95M
Book Value Per Share0.97
Working Capital1.92B

Margins

Gennex Laboratories Limited operates with a gross margin of 25.60, reflecting its pricing power and cost economics. The operating margin of 14.15 and net profit margin of 11.43 provide insight into operational efficiency.

Gross Margin25.60
Operating Margin14.15
Pretax Margin13.63
Profit Margin11.43
EBITDA Margin14.15

Stock Splits

Gennex Laboratories Limited's most recent stock split took place on July 21, 2022 with a 125:131 split ratio.

Last Split Date7/21/2022
Split Ratio125:131

Scores

Gennex Laboratories Limited posts an Altman Z-Score of 2.33, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.33